United States· US:69396-183_50c3acdd-43a2-09fd-e063-6394a90a7e63
Feminine Anti Itch Cream
A medicinal product containing benzocaine; resorcinol, registered in United States by TRIFECTA PHARMACEUTICALS USA LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BENZOCAINE; RESORCINOL
- Manufacturer
- TRIFECTA PHARMACEUTICALS USA LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1169396183011 TUBE in 1 BOX (69396-183-01) / 28.4 g in 1 TUBE
- ndc1169396183333 TUBE in 1 BOX (69396-183-33) / 28.4 g in 1 TUBE
- ndc1169396-183-01
- ndc1169396-183-33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddd400d6-8bb5-4561-abb9-301782085b0a GET /v1/drugs/ddd400d6-8bb5-4561-abb9-301782085b0a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "20; 3",
"substance": "BENZOCAINE; RESORCINOL",
"productndc": "69396-183",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g",
"application_number": "M017",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about benzocaine; resorcinol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.